Ste-Marie-des-Champs, France

Jacky Blanchard

This inventor holds 1 USPTO granted patent. Top assignee: Les Laboratories Servier. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacky Blanchard: Innovator in Pharmaceutical Chemistry

Introduction

Jacky Blanchard is a notable inventor based in Ste-Marie-des-Champs, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and formulations. His work has implications for the synthesis of important therapeutic compounds.

Latest Patents

Jacky Blanchard holds a patent for a process titled "Process for the preparation of 11-amino-3-chloro-6, 11-dihydro-5, 5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine and application to the synthesis of tianeptine." This patent highlights his expertise in developing methods for synthesizing complex chemical structures that are vital for medical applications. He has 1 patent to his name.

Career Highlights

Blanchard is associated with Les Laboratories Servier, a prominent pharmaceutical company known for its research and development in innovative therapies. His role at the company has allowed him to contribute to various projects aimed at improving mental health treatments.

Collaborations

Throughout his career, Jacky has collaborated with esteemed colleagues such as Hugues Turbe and Daniel Brigot. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jacky Blanchard's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for future developments in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…